StockDrifts LogoStockDrifts

Redmile Group 13F Portfolio ยท Jeremy Green

Portfolio Manager
Jeremy Green
Performance
+21.59% (2026 Q2)
AUM (13F)
$1.49B
# of Holdings
39
Performance Rank
Allocation (Top 20)
90%
Latest filing
Q2 2026

Redmile Group LLC Holdings Map

Top 38 Redmile Group LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
SRRK
SCHOLAR ROCK HLDG CORP
15.92%4.31M$237.1M
-52.45%(-4.76M)
2025-Q2: 3.93M shares2025-Q3: 3.90M shares2025-Q4: 5.22M shares2026-Q1: 9.07M shares2026-Q2: 4.31M shares
$30.76(+70.73%)
2026-06-30
KRYS
KRYSTAL BIOTECH INC
15.77%632.0K$234.9M
-6.16%(-41.50K)
2025-Q2: 663.5K shares2025-Q3: 661.4K shares2025-Q4: 677.7K shares2026-Q1: 673.5K shares2026-Q2: 632.0K shares
$67.06(+395.47%)
2026-06-30
STOK
STOKE THERAPEUTICS INC
8.67%3.95M$129.1M
-5.24%(-218.20K)
2025-Q2: 4.38M shares2025-Q3: 4.18M shares2025-Q4: 4.03M shares2026-Q1: 4.16M shares2026-Q2: 3.95M shares
$11.42(+173.70%)
2026-06-30
IMNM
IMMUNOME INC
6.99%4.91M$104.1M
-11.64%(-647.29K)
2025-Q2: 4.87M shares2025-Q3: 5.02M shares2025-Q4: 5.72M shares2026-Q1: 5.56M shares2026-Q2: 4.91M shares
$11.63(+133.83%)
2026-06-30
NRIX
NURIX THERAPEUTICS INC
6.64%4.07M$98.8M
-47.32%(-3.66M)
2025-Q2: 3.73M shares2025-Q3: 3.68M shares2025-Q4: 8.09M shares2026-Q1: 7.73M shares2026-Q2: 4.07M shares
$19.18(+41.03%)
2026-06-30
ABSI
ABSCI CORPORATION
5.24%6.74M$78.1M
-18.34%(-1.51M)
2025-Q2: 8.25M shares2025-Q3: 8.25M shares2025-Q4: 8.25M shares2026-Q1: 8.25M shares2026-Q2: 6.74M shares
$11.45(-19.82%)
2026-06-30
ANNX
ANNEXON INC
4.55%11.87M$67.8M
-18.42%(-2.68M)
2025-Q2: 6.30M shares2025-Q3: 6.30M shares2025-Q4: 10.05M shares2026-Q1: 14.55M shares2026-Q2: 11.87M shares
$10.10(-47.62%)
2026-06-30
RGNX
REGENXBIO INC
3.51%4.37M$52.3M
+0.00%(+0)
2025-Q2: 4.78M shares2025-Q3: 4.69M shares2025-Q4: 4.37M shares2026-Q1: 4.37M shares2026-Q2: 4.37M shares
$22.29(-51.71%)
2026-06-30
STTK
SHATTUCK LABS INC
3.21%6.89M$47.8M
+24.41%(+1.35M)
2025-Q2: 5.54M shares2025-Q3: 5.54M shares2025-Q4: 5.54M shares2026-Q1: 5.54M shares2026-Q2: 6.89M shares
$43.39(-82.90%)
2026-06-30
NGNE
NEUROGENE INC
2.98%1.41M$44.4M
-3.25%(-47.40K)
2025-Q2: 1.28M shares2025-Q3: 1.30M shares2025-Q4: 1.46M shares2026-Q1: 1.46M shares2026-Q2: 1.41M shares
$22.50(+60.64%)
2026-06-30

About Redmile Group LLCโ€™s portfolio

Redmile Group LLC reports $1.49B in US-listed equity holdings across 39 positions in its most recent 13F filing. Its largest disclosed positions are SRRK (15.9%), KRYS (15.8%) and STOK (8.7%). The top 20 holdings account for 90% of reported assets. Its disclosed equity book has returned +70.25% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
SRRK โ€” 16.0% ($237.11M)KRYS โ€” 15.9% ($234.90M)STOK โ€” 8.7% ($129.11M)IMNM โ€” 7.0% ($104.08M)NRIX โ€” 6.7% ($98.83M)ABSI โ€” 5.3% ($78.11M)ANNX โ€” 4.6% ($67.78M)RGNX โ€” 3.5% ($52.34M)STTK โ€” 3.2% ($47.83M)NGNE โ€” 3.0% ($44.41M)Other โ€” 26.1% ($387.06M)
74%in top 10
  • SRRK16.0%
  • KRYS15.9%
  • STOK8.7%
  • IMNM7.0%
  • NRIX6.7%
  • ABSI5.3%
  • ANNX4.6%
  • RGNX3.5%
  • STTK3.2%
  • NGNE3.0%
  • Other26.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
3
CLYMCLIMB BIO INC1.1%
AURAAURA BIOSCIENCES INC0.8%
INSMINSMED INC0.4%
Added to
5
AGMBAGOMAB THERAPEUTICS NV+1649.7%
STTKSHATTUCK LABS INC+24.4%
CLDXCELLDEX THERAPEUTICS INC NEW+65.9%
BMRNBIOMARIN PHARMACEUTICAL INC+52.5%
+1 more
Trimmed
23
SRRKSCHOLAR ROCK HLDG CORP-52.5%
NRIXNURIX THERAPEUTICS INC-47.3%
ABSIABSCI CORPORATION-18.3%
KRYSKRYSTAL BIOTECH INC-6.2%
+19 more

Unlock alerts, watchlists & AI chat

Sign up free to track Redmile Group LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Redmile Group LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1425738). View Redmile Group LLCโ€™s 13F filings on SEC

More 13F analyses

View all